BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22828012)

  • 1. Comparison of urinary and serum levels of di-22:6-bis(monoacylglycerol)phosphate as noninvasive biomarkers of phospholipidosis in rats.
    Thompson KL; Zhang J; Stewart S; Rosenzweig BA; Shea K; Mans D; Colatsky T
    Toxicol Lett; 2012 Sep; 213(2):285-91. PubMed ID: 22828012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the diagnostic accuracy of di-22:6-bis(monoacylglycerol)phosphate and other urinary phospholipids for drug-induced phospholipidosis or tissue injury in the rat.
    Thompson KL; Haskins K; Rosenzweig BA; Stewart S; Zhang J; Peters D; Knapton A; Rouse R; Mans D; Colatsky T
    Int J Toxicol; 2012; 31(1):14-24. PubMed ID: 22267869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipidosis in rats treated with amiodarone: serum biochemistry and whole genome micro-array analysis supporting the lipid traffic jam hypothesis and the subsequent rise of the biomarker BMP.
    Mesens N; Desmidt M; Verheyen GR; Starckx S; Damsch S; De Vries R; Verhemeldonck M; Van Gompel J; Lampo A; Lammens L
    Toxicol Pathol; 2012 Apr; 40(3):491-503. PubMed ID: 22291062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Di-22:6-bis(monoacylglycerol)phosphate: A clinical biomarker of drug-induced phospholipidosis for drug development and safety assessment.
    Liu N; Tengstrand EA; Chourb L; Hsieh FY
    Toxicol Appl Pharmacol; 2014 Sep; 279(3):467-476. PubMed ID: 24967688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers to monitor drug-induced phospholipidosis.
    Baronas ET; Lee JW; Alden C; Hsieh FY
    Toxicol Appl Pharmacol; 2007 Jan; 218(1):72-8. PubMed ID: 17156806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualified method for the estimation of di-18:1 bis(monoacylglycero)phosphate in urine, a noninvasive biomarker to monitor drug-induced phospholipidosis.
    Murali BV; Kurawattimath V; Bhutani P; Onorato J; Naikodi SB; Kole P; Rajanna PK
    Bioanalysis; 2020 Aug; 12(15):1049-1059. PubMed ID: 32735140
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship between in vitro phospholipidosis assay using HepG2 cells and 2-week toxicity studies in rats.
    Miyamoto S; Matsumoto A; Mori I; Horinouchi A
    Toxicol Mech Methods; 2009 Oct; 19(8):477-85. PubMed ID: 19793005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular biomarkers of phospholipidosis in rat blood and heart after amiodarone treatment.
    Bocchini N; Giantin M; Crivellente F; Ferraresso S; Faustinelli I; Dacasto M; Cristofori P
    J Appl Toxicol; 2015 Jan; 35(1):90-103. PubMed ID: 25580480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of urinary microRNA profiles in rats that may diagnose hepatotoxicity.
    Yang X; Greenhaw J; Shi Q; Su Z; Qian F; Davis K; Mendrick DL; Salminen WF
    Toxicol Sci; 2012 Feb; 125(2):335-44. PubMed ID: 22112502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic Phospholipidosis Is Associated with Altered Hepatobiliary Function as Assessed by Gadoxetate Dynamic Contrast-enhanced Magnetic Resonance Imaging.
    Lenhard SC; Lev M; Webster LO; Peterson RA; Goulbourne CN; Miller RT; Jucker BM
    Toxicol Pathol; 2016 Jan; 44(1):51-60. PubMed ID: 26516164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multiplexed UPLC-MS/MS assay for the simultaneous measurement of urinary safety biomarkers of drug-induced kidney injury and phospholipidosis.
    Tengstrand E; Zhang H; Liu N; Dunn K; Hsieh F
    Toxicol Appl Pharmacol; 2019 Mar; 366():54-63. PubMed ID: 30653977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of a potential biomarker of phospholipidosis from amiodarone-treated rats.
    Mortuza GB; Neville WA; Delaney J; Waterfield CJ; Camilleri P
    Biochim Biophys Acta; 2003 Mar; 1631(2):136-46. PubMed ID: 12633679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum neopterin levels in acetaminophen-induced liver injury.
    Demirbas S; Cakir E; Akgul EO; Seyrek M; Cayci T; Kurt YG; Uysal B; Aydin I; Kurt B; Yaman H; Erbil MK
    Environ Toxicol Pharmacol; 2011 Jan; 31(1):165-70. PubMed ID: 21787682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenylacetylglycine, a putative biomarker of phospholipidosis: its origins and relevance to phospholipid accumulation using amiodarone treated rats as a model.
    Delaney J; Neville WA; Swain A; Miles A; Leonard MS; Waterfield CJ
    Biomarkers; 2004; 9(3):271-90. PubMed ID: 15764292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary metabolic fingerprinting for amiodarone-induced phospholipidosis in rats using FT-ICR MS.
    Hasegawa M; Takenaka S; Kuwamura M; Yamate J; Tsuyama S
    Exp Toxicol Pathol; 2007 Oct; 59(2):115-20. PubMed ID: 17719757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro detection of drug-induced phospholipidosis using gene expression and fluorescent phospholipid based methodologies.
    Nioi P; Perry BK; Wang EJ; Gu YZ; Snyder RD
    Toxicol Sci; 2007 Sep; 99(1):162-73. PubMed ID: 17567588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bis(monoacylglycero)phosphate, a new lipid signature of endosome-derived extracellular vesicles.
    Rabia M; Leuzy V; Soulage C; Durand A; Fourmaux B; Errazuriz-Cerda E; Köffel R; Draeger A; Colosetti P; Jalabert A; Di Filippo M; Villard-Garon A; Bergerot C; Luquain-Costaz C; Moulin P; Rome S; Delton I; Hullin-Matsuda F
    Biochimie; 2020 Nov; 178():26-38. PubMed ID: 32659447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentraxin 3 as a potential biomarker of acetaminophen-induced liver injury.
    Yaman H; Cakir E; Akgul EO; Aydin I; Onguru O; Cayci T; Kurt YG; Agilli M; Aydin FN; Gulec M; Altinel O; Isbilir S; Ersoz N; Yasar M; Turker T; Bilgi C; Erbil KM
    Exp Toxicol Pathol; 2013 Jan; 65(1-2):147-51. PubMed ID: 21880472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting in vivo phospholipidosis-inducing potential of drugs by a combined high content screening and in silico modelling approach.
    Bauch C; Bevan S; Woodhouse H; Dilworth C; Walker P
    Toxicol In Vitro; 2015 Apr; 29(3):621-30. PubMed ID: 25668432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analyses and transcriptomic profiling of circulating messenger RNAs as biomarkers of rat liver injury.
    Wetmore BA; Brees DJ; Singh R; Watkins PB; Andersen ME; Loy J; Thomas RS
    Hepatology; 2010 Jun; 51(6):2127-39. PubMed ID: 20235334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.